|
|
965 Atlantic Avenue
Alameda, CA 94501 USA
phone:510.865.8800
fax:510.865.5700
|
|
| Symbol |
INSV |
| Exchange |
OTC |
| Founded |
0 |
| Employees |
|
|
|
| www.insitevision.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Ophthalmic products focused on ocular infection, glaucoma, and retinal disease. |
|
| Management |
| Louis Drapeau, Chief Executive Officer, Vice President and Chief Financial Officer; Lyle M. Bowman, Ph.D., Vice President, Development and Operations; David Heniges, Vice President and General Manager, Commercial Opportunities; Kamran Hosseini, M.D., Ph.D., Vice President, Clinical Affairs and Chief Medical Officer; Surendra Patel, Vice President, Operations |
| |
|
|
|
|
|
|
|
| Keywords |
| eye, retinal, genomics, topical drug delivery, infection, glaucoma, DrugDelivery |
|
|
|
| Description |
|
InSite Vision is an ophthalmic products company currently focused on ocular infection, glaucoma, and retinal disease. The Company specializes in three platform technologies: topical drug delivery (DuraSite), genomics, and retinal drug delivery. As a result, the Company has a portfolio of both diagnostic and therapeutic products in early and late-stage development. |
|
| Products / Services |
The Company's lead product, AzaSite, targets infection of the eye. AzaSite is formulated with DuraSite, InSite Vision's patented drug-delivery vehicle, which offers the prolonged release of an active ingredient. This formulation could offer the benefit of a low-dosing regimen, attractive to both the eye-care patient and physician.
|
|
| Technology / Differentiation |
| Genomics: InSite Vision is working to incorporate genomic technologies into standard clinical therapies for ophthalmic diseases like glaucoma. DuraSite technology can be customized to deliver a variety of drug compounds within a broad range of molecular weights and other properties. Use of DuraSite technology may lead to lower drug concentration, resulting in the reduction of related side effects associated with higher drug concentration. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
